Weight management is one of the most significant public health challenges in Australia, with roughly two-thirds of adults classified as overweight or obese. Increasingly, patients are asking their GPs about medical options — and telehealth is making those conversations more accessible.
The Clinical Assessment Process
A ConsultNow weight management consultation starts with a thorough clinical assessment:
- Current weight and BMI
- Medical and medication history
- Previous weight loss attempts
- Diet and exercise habits
- Relevant blood results
From this assessment, your GP can advise on lifestyle approaches, discuss medication options where appropriate, and help you build a realistic plan.
GLP-1 Receptor Agonists (Ozempic, Wegovy)
The GLP-1 receptor agonist class — which includes semaglutide, marketed as Ozempic and Wegovy — has attracted significant attention due to its effectiveness in clinical trials. These medications are approved in Australia and can be discussed in a telehealth consultation, though prescribing requires careful clinical assessment and ongoing monitoring.
Medications as Part of a Broader Plan
Not everyone is a candidate for weight-loss medication, and our GPs will tell you honestly if they feel other approaches are more appropriate. Medications are tools — they work best as part of a broader plan that includes dietary changes, physical activity, and behavioural support. A prescription in isolation rarely produces sustainable results.
Why Regular Monitoring Matters
The availability of telehealth means ongoing monitoring — regular check-ins every four to six weeks, dose adjustments, blood pressure reviews, pathology — is much easier to maintain. This regular contact is what makes medical weight management effective over the medium and long term.

